PCTR1, via the activation of the lipoxin A4 receptor, promotes the conversion of linoleic acid to arachidonic acid (AA) through upregulation of the desaturases FADS1, FADS2, and ELOVL2 expression. It ...
EatingWell on MSN
No, you don't actually need to do a liver detox—here's why
Detox teas and cleanses promise to flush toxins, but your liver already does that work. Here's what detox really means and what actually supports liver health.
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- Clinical and translational medicine will ...
Dr. Saurabh Sethi notes that most people believe sugar affects weight. However, it can strongly influence your liver.
In recognition of World Diabetes Day, Phospholipids (Essentiale Forte P), the No. 1 liver health brand from Opella, is urging Filipinos to look beyond blood sugar and recognize the liver’s overlooked ...
The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre & post liver transplant, ...
South Florida specialists want people to know that repairing your liver is possible, and laying off alcohol in January is only one way to kick-start the process. The liver performs more than 500 ...
The Lipids & Liver group at the UPV/EHU-University of the Basque Country is stepping up research into liver diseases that affect a significant proportion of the population One of the lines of research ...
WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) ...
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND and/or ...
MORRISTOWN, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (ICPT) today announced a restructuring to strengthen the Company’s focus on rare and serious liver diseases and ...
A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback